A Review on Targeted Drug Delivery System

Vamsi Sripathi

doi:10.37022/jpmhs.v7i2.109

Authors

Sripathi Vamsi Priyadarshini Institute of Pharmaceutical Education and Research, 5th Mile, Pulladigunta, Guntur-522017.Andhra Pradesh, India.

DOI:

https://doi.org/10.37022/jpmhs.v7i2.109

Keywords:

Targeted drug delivery, Microspheres, Nanoparticles, Liposomes, Monoclonal antibodies, Brain targeted drug delivery system

Abstract

Good drug delivery, also known as targeted drug administration, is a therapeutic approach that involves administering more medication to one or a few body parts than to others. Two tactics are Cancers Active and passive targeting is commonly employed to focus drugs to a certain organ or tissue. Delivery of drugs Cars provide the medication either continuously or only in the desired area. A perfect medicine delivery vehicle should be able to pass across barriers like the blood-brain barrier. Because nanotechnology is being used in medicine, nanomedicine has recently gained popularity. Nano drug delivery can help distribute medications with limited water solubility and can help prevent the first pass because nanoparticles are incredibly small. Liver metabolism. Medication delivery based on nanotechnology. These also include the approaches in which the therapeutic drugs are combined with "targeting ligands"—antigens linked to tumors—that have this potential.

Downloads

Download data is not yet available.

References

Katakam P, Dey B, Assaleh FH, Hwisa NT, Adiki SK, Chandu BR, Mitra A. Top-down and bottom-up approaches in 3D printing technologies for drug delivery challenges. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2015;32(1).

Vasam M, Sriharsha SN, Bhukya S. Composition, formulation and in-vitro evaluation studies of cefixime microspheres. In2016 International Conference on Electrical, Electronics, and Optimization Techniques (ICEEOT) 2016 Mar 3 (pp. 3391-3396). IEEE.

Bhargav E, Madhuri N, Ramesh K, Manne A, Ravi V. Targeted drug delivery-a review. World J Pharm Pharm Sci. 2013;3(1):150-69. https://www.researchgate.net/publication/228096587_Microspheres-_An_overview

Kumar A, Sharma A. Computational modeling of multi-target-directed inhibitors against Alzheimer’s disease. Computational modeling of drugs against Alzheimer’s disease. 2018:533-71. https://www.researchgate.net/publication/320085377_Computational_Modeling_of_Multi-

Huang S, Kauffman S. How to escape the cancer attractor: rationale and limitations of multi-target drugs. InSeminars in cancer biology 2013 Aug 1 (Vol. 23, No. 4, pp. 270-278). Academic Press. https://pubmed.ncbi.nlm.nih.gov/23792873/

Pinheiro M, Lúcio M, Lima JL, Reis S. Liposomes as drug delivery systems for the treatment of TB. Nanomedicine. 2011 Oct;6(8):1413-28.

https://pubmed.ncbi.nlm.nih.gov/22026379/

Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis. Cancer science. 2004 May;95(5):377-84. https://pubmed.ncbi.nlm.nih.gov/15132763/ )

Hirsjarvi S, Passirani C, Benoit JP. Passive and active tumour targeting with nanocarriers. Current drug discovery technologies. 2011 Sep 1;8(3):188-96.

Lee MJ, Lee MH, Shim CK. Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338. International journal of pharmaceutics. 1995 Jan 16;113(2):175-87.

Nama S, Chandu BR, Khagga M. A new RP-HPLC method development and validation of orlistat in bulk and pharmaceutical dosage forms. Int J Pharm Sci Rev Res. 2010;1(6):251-7.

Sobana S, Prabha SK, Seerangurayar T, Sudha S. Securing future autonomous applications using cyber-physical systems and the Internet of Things. InHandbook of Research of Internet of Things and Cyber-Physical Systems 2022 Jun 8 (pp. 81-148). Apple Academic Press. https://www.intechopen.com/books/2509

Maddineni S, Chandu B, Ravilla S, Nama S, Pradesh A. Dissolution research-a predictive tool for conventional and novel dosage forms. Asian J Pharm Life Sci. 2012;2231:4423.

Chowdary KP, Chandra DU, Mahesh N, Reddy TM, Gopaiah KV. Enhancement of dissolution rate and formulation development of pioglitazone-a BCS class II drug. J. Pharm. Res. 2011 Nov;4:3862-3.

https://docplayer.net/amp/54559585-Targeted-drug-delivery-a-review.html

Swami A, Shi J, Gadde S, Votruba AR, Kolishetti N, Farokhzad OC. Nanoparticles for targeted and temporally controlled drug delivery. Multifunctional nanoparticles for drug delivery applications: imaging, targeting, and delivery. 2012:9-29. https://www.google.com/amp/s/docplayer.net/amp/54559585-Targeted-drug-delivery-a-

Arredondo-Ochoa T, Silva-Martínez GA. Microemulsion based nanostructures for drug delivery. Frontiers in Nanotechnology. 2022 Jan 6;3:753947.

Yu W, Rahimi R, Ochoa M, Pinal R, Ziaie B. A smart capsule with GI-tract-location-specific payload release. IEEE Transactions on Biomedical Engineering. 2015 Apr 20;62(9):2289-95.

Joshi MD, Unger WJ, Storm G, Van Kooyk Y, Mastrobattista E. Targeting tumor antigens to dendritic cells using particulate carriers. Journal of controlled release. 2012 Jul 10;161(1):25-37.

Tamarkin D, Eini M, Friedman D, Besonov A, Schuz D, Berman T, Danziger J, Keynan R, Zlatkis E, inventors; Foamix Ltd, assignee. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses. United States patent US 8,486,374. 2013 Jul 16. https://patents.google.com/patent/US8486374B2/enb